By elucidating the precise mechanisms through which natural compounds modulate PCSK9, more targeted and effective dietary strategies can be developed to complement conventional pharmacotherapy in the treatment of hypercholesterolemia and associated cardiovascular risks. The gene discussed is PCSK9; the disease is familial hypercholesterolemia.